• Your Selections:

Refine Results

date

Topics

Content Type

Tags

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2021

This report tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to multilateral organizations. Donor governments disbursed US$7.5 billion in 2021, largely flat amid the COVID-19 pandemic and essentially matching 2008 levels.

The U.S. Government & Gavi, the Vaccine Alliance

This fact sheet examines the Gavi, the Vaccine Alliance (also known as Gavi), an independent, public-private partnership and multilateral funding mechanism that aims to increase access to immunization in poor countries, and explores the role the U.S. government plays in supporting the partnership.

KFF/UNAIDS Analysis Finds That While Donor Government Spending on HIV Increased in 2020, Future Funding is Uncertain with COVID-19 Challenges

A new report from KFF (Kaiser Family Foundation) and The Joint United Nations Programme on HIV/AIDS (UNAIDS) finds that donor government disbursements to combat HIV in low- and middle-income countries increased by US$377 million in 2020, reaching US$8.2 billion in 2020 compared to US$7.8 billion in 2019. Donor government funding…

Putting U.S. Global COVID-19 Vaccine Donations in Context

While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country.  In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.

The U.S. Government and Global Health Security

This brief examines the U.S. government’s efforts in global health security – that is, activities to help countries prepare for and develop capacities to address epidemic and pandemic diseases. The brief provides history and background, outlines the U.S. agencies carrying out these efforts, describes funding, and highlights key policy issues going forward.

What Could the U.S. Do to Help Improve Global COVID-19 Vaccine Equity?

As India and other countries continue to grapple with major COVID-19 outbreaks even as cases decline in this country, there is increasing attention to the global role that could be played by the U.S. government.  This is particularly the case now that the U.S. will soon have enough COVID-19 vaccine…

Global COVID-19 Vaccine Equity: U.S. Policy Options and Actions to Date

This brief examines U.S. policy options for helping expand global access to COVID-19 vaccines, focusing on four main areas: in-kind donations of vaccine doses, additional funding for global access mechanisms like COVAX, helping expand global vaccine manufacturing, and relaxing or waiving intellectual property protections on vaccine technologies. We summarize what the administration has done to date in these areas and policy issues related to each.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.